S.Amdt. 5194

SA 5194. Mr. MERKLEY submitted an amendment intended to be proposed
by him to the concurrent resolution S. Con. Res. 33, setting forth the
congressional budget for the United States Government for fiscal year
2026 and setting forth the appropriate budgetary levels for fiscal
years 2027 through 2035; which was ordered to lie on the table; as
follows:

At the end of title III, add the following:

[[Page S2004]]

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO REDUCING
FEDERAL SPENDING FOR PRESCRIPTION DRUGS.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution,
and make adjustments to the pay-as-you-go ledger, for one or
more bills, joint resolutions, amendments, amendments between
the Houses, motions, or conference reports relating to
reducing health care costs, which may include legislation
enabling Americans to have a much improved opportunity to
purchase prescription drugs at, or near, the lower prices
manufacturers charge in other similarly developed nations,
requiring pharmaceutical manufactures to report annually the
amount of taxpayer dollars used to benefit manufacturers'
research and development efforts, or enacting other
mechanisms to purchase prescription drugs at lower prices, by
the amounts provided in such legislation for those purposes,
provided that such legislation would not increase the deficit
over the period of the total of fiscal years 2026 through
2035.
______